Loading company…
Passkey Therapeutics develops multifunctional medicines for complex diseases using computational and experimental drug discovery.
Based in Cambridge, Passkey Therapeutics develops Synergistic Multifunctional Therapeutics for complex diseases, including cancer, autoimmune, neurodegenerative and metabolic disorders. Its Locksmith platform identifies combinations of interacting proteins as potential drug targets. The company was founded by Bruce Beutel, Soumya Ray and William Chen. In June 2024, it raised USD 19.35 mn in Seed funding led by Breakout Ventures, with participation from other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in